Chronic treatment with Parlodel LAR® of patients with prolactin-secreting tumours. Different responsiveness of micro- and macroprolactinomas

Abstract

a. injectable bromocriptine (Parlodel LAR) is a highly effective preparation particularly suitable for the long-term treatment of tumourous hyperprolactinemia; b. patients with macroprolactinoma exhibit, compared with microprolactinoma patients, better responsiveness and better tolerability to injectable bromocriptine.